The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase 2 study of fruquintinib in combination with S-1 for second-line treatment of esophageal squamous cell carcinoma after first-line immunotherapy failure.
 
Ningning Li
No Relationships to Disclose
 
Yuping Ge
No Relationships to Disclose
 
Xiang Wang
No Relationships to Disclose
 
Wei Qiu
No Relationships to Disclose
 
Zhiyang Zhang
No Relationships to Disclose
 
Na Zhou
No Relationships to Disclose
 
Lin Zhao
No Relationships to Disclose